摘要: |
目的 探究严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)S1 蛋白诱导呼吸道上皮细胞炎症反应机制
以及嘌呤能受体(P2Y2)参与S1 蛋白引起的炎症反应。方法 酶联免疫吸附实验(ELISA)测量S1 蛋白和/或单克隆抗
体(MAb)刺激的 16HBE14o-细胞培养上清中白介素-6(IL-6)、白介素-8(IL-8)和腺嘌呤核苷三磷酸(ATP)水平,实时
荧光定量聚合酶链反应(qRT-PCR)检测血红素氧合酶 1(HO-1)、双特异性磷酸酶 1(MKP-1)和P2Y2 mRNA的转录水
平;小干扰RNA(siRNA)敲低P2Y2 表达后,ELISA检测S1 蛋白刺激的 16HBE14o-细胞培养上清中IL-6 和IL-8 水平。
结果 S1 蛋白和MAb对细胞活力无显著影响(P>0.05)。S1 蛋白刺激 16HBE14o-细胞引起IL-6 和IL-8 分泌增加,上调
HO-1、MKP-1 和P2Y2 mRNA表达,增加了胞外ATP水平(P<0.001 或 0.01),MAb显著抑制了S1 蛋白引起的IL-6 和IL-8
分泌(P<0.001 或 0.01)。siRNA敲低P2Y2 的表达能够显著降低S1 蛋白诱导的IL-6 和IL-8 分泌,同时ERK1/2 抑制剂
PD98059 也抑制了S1 蛋白引起的IL-6 和IL-8 分泌(P<0.001)。结论 SARS-CoV-2 S1 蛋白能够通过ATP/P2Y2 和ERK
信号通路诱导呼吸道上皮细胞发生炎症反应。 |
关键词: SARS-CoV-2 S1 蛋白 胞外ATP ERK1/2 支气管上皮细胞 炎症 |
DOI: |
|
基金项目:国家自然科学基金(82000008) |
|
SARS-CoV-2 spike S1 protein promotes IL-6 and IL-8 release via ATP/P2Y2 and ERK1/2 signaling pathways in human bronchial epithelial cells |
|
() |
Abstract: |
Objective To explore the mechanisms by which SARS-CoV-2 S1 protein induce pro-inflammatory responses
in human bronchial epithelial cells and purinegic receptors were involved in the inflammatory by the S1 protein stimulation.
Methods The pro-inflammatory cytokine (interleukin-6) IL-6 and (interleukin-8) IL-8 secretion and adenosine triphosphate
(ATP) level in16HBE14o- cells induced by S1 protein and/or monoclonal antibody (MAb) were determined by using Enzymelinked immunosorbent assay (ELISA). The (Heme Oxygenase-1) HO-1, (dual specificity phosphatases-1) MKP-1 and P2Y2
mRNA expression in 16HBE14o- cells after S1 protein stimulation were determined by Real-time quantitative fluorescence
PCR (qRT-PCR). Small interfering RNA (siRNA) knockdown P2Y2 expression ELISA detected the IL-6 and IL-8 release in
16HBE14o- cells after S1 protein stimulation. Results S1 protein and MAb hadno significant effects on cell viability (P>0.05).
S1 protein induced IL-6 and IL-8 secretion, regulated HO-1, MKP-1, and P2Y2 mRNA expression, and increased extracellular
ATP levels in 16HBE14o- cells(P<0.001 or 0.01).The MAb significantly inhibited the secretion of IL-6 and IL-8 induced byS1
protein (P<0.001 or 0.01). siRNA knockdown of P2Y2 expression significantly reduced S1 protein-induced IL-6 and IL-8
secretion, while ERK1/2 inhibitor PD98059 also inhibited S1 protein-induced IL-6 and IL-8 secretion (P<0.001). Conclusion
SARS-CoV-2 S1 protein induce inflammatory responses in respiratory epithelial cells through the ATP/P2Y2 and ERK signaling
pathways. |
Key words: SARS-CoV-2 S1 protein extracellular ATP ERK1/2 bronchial epithelial cells inflammation |